Recon Technology
RCON
3 hedge funds and large institutions have $35K invested in Recon Technology in 2017 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 0 closing their positions.
84% more capital invested
Capital invested by funds: $19K → $35K (+$16K)
50% more funds holding
Funds holding: 2 → 3 (+1)
0% more ownership
Funds ownership: 0% → 0.01% (+0%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
+$17.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$285 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TSS
1
Two Sigma Securities
New York
| $18K | +$17.6K | +186 | New |
|
2
Goldman Sachs
New York
| $11K | – | – | – |
|
|
3
UBS Group
Zurich,
Switzerland
| $6K | -$285 | -3 | -4% |
|
RCON Hedge Fund Activity: Q3 2017 in Review
3 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Recon Technology (RCON) for Q3 2017, worth a combined $35K — up 84% from $19K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new RCON positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Two Sigma Securities, opening a new position worth an estimated $17.6K. The largest seller was UBS Group, cutting an estimated $285.
- 3 institutional investors held Recon Technology (RCON) as of Q3 2017, up from 2 in Q2 2017.
- Funds reported $35K of Recon Technology stock for Q3 2017, up 84% quarter-over-quarter.
- 1 fund opened new Recon Technology positions in Q3 2017 and 0 closed out, a net change of +1 holder.
- The largest Recon Technology buyer in Q3 2017 was Two Sigma Securities, an estimated $17.6K added.
- The largest Recon Technology seller in Q3 2017 was UBS Group, an estimated $285 sold.
Based on aggregated 13F filings for Q3 2017.